Despite the claims by Schaefer et al. being subsequently retracted, (Nutter et al., 2018) these preliminary findings raise important questions on how CRISPR-induced p53 dysregulation may result in abnormal and uncontrollable cell division, and an increased cancer risk. The gene discussed is TP53; the disease is cancer.